Advanced Therapies and Enterprise Journal Club
QS IoN has launched a bi-monthly journal club on advanced therapies and enterprise. During the journal club, we will critically review the experimental plan, comment on the target product profile (TPP), analyse the competition and intellectual property position. We will have a tech transfer office (TTO) manager, translational research managers, business and innovation experts and an external guest.
- Have the chance to discuss together gene therapy experimental design by analysing peer reviewed papers
- Learn about patents and intellectual property with a UCL tech transfer manager and using real-world example
- Ask questions about how your research can have the quickest and biggest impact for patients
Article: Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome (Fadila, 2023, J Clin Invest.)
Hybrid meeting - also on Teams.
Contact: e.lugara@ucl.ac.uk
Further information
Ticketing
Ticketed and Pre-booking essential
Cost
Free
Open to
UCL staff
Availability
Yes